Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Amortization of Deferred Charges (2016 - 2025)

Historic Amortization of Deferred Charges for Dare Bioscience (DARE) over the last 7 years, with Q3 2025 value amounting to $124251.0.

  • Dare Bioscience's Amortization of Deferred Charges changed N/A to $124251.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $135873.0, marking a year-over-year increase of 15007.83%. This contributed to the annual value of $316805.0 for FY2017, which is 2457.02% down from last year.
  • According to the latest figures from Q3 2025, Dare Bioscience's Amortization of Deferred Charges is $124251.0.
  • Dare Bioscience's 5-year Amortization of Deferred Charges high stood at $124251.0 for Q3 2025, and its period low was -$5910.0 during Q2 2025.